Physician profile
Stephen W Downing
NPI 1104861178
$8,997.27
in general payments reported to CMS, 2019-2025
12 companies · $1,450 in 2025
The $1,450 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,456 · 2020: $1,220 · 2021: $960 · 2022: $572 · 2023: $1,046 · 2024: $295 · 2025: $1,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,624 · Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,623.60 |
| Food and Beverage | $1,166.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,148.30 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Konect Resilia |
| Abbott Laboratories | $1,752.44 | 2019-2021 | |
| Medtronic Vascular, INC. | $1,060.35 | 2019-2020 | |
| Abiomed | $1,004.22 | 2019-2025 | Impella |
| Artivion, INC. | $374.19 | 2022 | |
| Medtronic, INC. | $260.31 | 2021-2023 | Corevalve Evolut R |
| Inari Medical, INC. | $168.39 | 2021-2022 | |
| Terumo Cardiovascular Systems Corporation | $133.28 | 2019 | |
| Galvanize Therapeutics, INC | $34.42 | 2024 | Aliya System |
| Getinge USA Sales, LLC | $32.13 | 2021 | |
| Smith+Nephew, INC. | $16.30 | 2023 | Renasys Touch, Renasys Go V2 Home, Pico |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.94 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Downing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.